News Overview

Ashish Goenka and Harsha Vardhan Agarwal has submitted to the Exchange a copy of Disclosure under Regulation 10(5) Intimation to stock Exchanges in respect of acquisition under Regulation 10(1) (a) of SEBI ( SAST) Regulations, 2011

Lincoln Pharmaceuticals Limited has informed the Exchange about demise of Ishwarlal Ambalal Patel as Independent Director of the company w.e.f. 04-Dec-2022

Inox Green Energy Services Limited has informed the Exchange about Board Meeting held on 02-Dec-2022 to consider financial statements for the period ended September 2022 and Other business matters

POWERGRID : The Exchange has sought clarification from Power Grid Corporation of India Limited with respect to recent news item captioned Power Grid to separate telecom biz, gets nod to foray into data centre biz. The response from the Company is awaited.

HPL Electric & Power Limited has informed the Exchange about press release dated 05-Dec-2022 titled Press Release

Relaxo Footwears announced that ICRA has taken the following ratings action as under a Retained Long term rating of Rs 14000 crore on Fund based facilities of the Company at [ICRA] AA pronounced as ICRA double A The outlook on the long term rating has been revised to Stable from Positive b Retained Short term rating of Rs 12000 crore on Non fund based facilities […]

Titagarh Wagons has assigned additional role of Chief Business and Risk Officer to Anil Kumar Agarwal Director Finance CFO with effect from 28 November 2022 The company also appointed Saurav Singhania as Joint Chief Financial Officer Jt CFO of the Company wef 28 November 2022 designated as Joint CFO and Group Financial Controller

Dredging Corporation of India announced that the 46th Annual General Meeting AGM of the company will be held on 21 December 2022

Biocon Biologics subsidiary of Biocon announced today that it has successfully completed its multi-billion-dollar USD acquisition of the global biosimilars business of its partner Viatris Inc NASDAQ VTRS Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the US Federal Trade Commission the Competition Commission of India and the Reserve Bank of India and its investors Effective from the date […]

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 1 December 2022